The Institute
for Clinical and Economic Review is seeking new members for the New England
Comparative Effectiveness Public Advisory Council, in addition to two other councils
in California and the Midwest. Many health policy experts blame new
technologies for drugs, devices and other innovations with driving health costs
up without necessarily improving the quality of care. The Councils include
leading clinician, patient and public representatives, researchers, and health
economists who meet a few times a year to consider, and vote on, the
effectiveness and value of new health treatments. Previous topics include
treatments for liver disease, multiple myeloma, and lung cancer, as well as
system-level interventions such as palliative care and diabetes prevention
programs. Members must meet conflict of interest guidelines and will be
reimbursed for travel to meetings and for their time. To apply, send a
CV/resume and letter of interest to info@icer-review.org
by December 15th. Learn more about ICER here,
here
and here.
